Related Experiment Videos
Reactive oxygen species in tumor progression
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. pstorz@bidmc.harvard.edu
Frontiers in Bioscience : a Journal and Virtual Library
|March 17, 2005
Summary
Reactive oxygen species (ROS) play a dual role in cancer, promoting tumor growth while also potentially inhibiting it. Understanding ROS mechanisms is crucial for cancer prevention and treatment strategies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Reactive oxygen species (ROS) are generated in mammalian cells and impact cellular functions.
- Impaired ROS detoxification is linked to human diseases.
- ROS act as second messengers in cancer cell signaling.
Purpose of the Study:
- To review the multifaceted roles of ROS in tumor development and progression.
- To explore the dual nature of ROS as both pro- and anti-tumorigenic agents.
Main Methods:
- Literature review of current knowledge on ROS in cancer.
- Analysis of cellular responses to ROS based on molecular context.
Main Results:
- ROS can promote cancer by increasing proliferation, survival, migration, and DNA damage.
- ROS can also induce cellular senescence and death, acting as anti-cancer agents.
- Cellular response to ROS is context-dependent (cell type, ROS location, concentration).
Conclusions:
- The role of ROS in cancer is complex and depends on various cellular and molecular factors.
- Elevated ROS production in carcinoma cells and tumor resistance to oxidative stress are observed.
- Antioxidant interventions show potential in cancer prevention, highlighting the significance of ROS research.